comprehensive -WSS

comprehensive

author：fashion 2025-10-01 23:00:03 - browse：2986

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Health and fitness trackers are measuring the wrong things

WSS

House transparency, PBM reform bill gains bipartisan support

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Why Novartis is changing the name of its research labs

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Amazon on where the company's health care bets are headed next

focus

comprehensive

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

As JPM 2024 winds down, some health tech firms project optimism

Peter Hotez and the public health issue of online harassment

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Caregivers of transplant patients call for more support, training

Malaria cases in Florida and Texas: Here’s what you need to know

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Activists slam private health insurers over coverage restrictions

Stem cell treatment guidelines are released by FDA

Wikipedia

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

ALS advocates say criticism of new drugs misses bigger picture

HHS names first

Ethical issues complicate the benefits of medical crowdfunding

Generative AI mines health records to identify patients’ social needs

Crinetics acromegaly drug succeeds in late

knowledge

hotspot

knowledge

Wikipedia